购物车
全部删除
您的购物车当前为空
GRK5-IN-2 是基于吡啶的双环化合物,抑制 G 蛋白偶联受体激酶 5 。它调节胰岛素的表达和/或释放,在代谢疾病中有研究价值。


为众多的药物研发团队赋能,
让新药发现更简单!
GRK5-IN-2 是基于吡啶的双环化合物,抑制 G 蛋白偶联受体激酶 5 。它调节胰岛素的表达和/或释放,在代谢疾病中有研究价值。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 173 | 现货 | |
| 5 mg | ¥ 416 | 现货 | |
| 10 mg | ¥ 672 | 现货 | |
| 25 mg | ¥ 1,330 | 现货 | |
| 50 mg | ¥ 1,990 | 现货 | |
| 100 mg | ¥ 2,830 | 现货 | |
| 200 mg | ¥ 3,960 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 467 | 现货 |
GRK5-IN-2 相关产品
| 产品描述 | GRK5-IN-2, a pyridine-based bicyclic compound, is a potent G-protein-coupled receptor kinase 5 (GRK5) inhibitor. It regulates the expression and/or release of insulin and is useful for the metabolic disease research. |
| 分子量 | 380.4 |
| 分子式 | C20H20N4O4 |
| CAS No. | 1642839-27-7 |
| Smiles | COc1cc(Nc2cc3n(C)c(nc3cn2)-c2ccco2)cc(OC)c1OC |
| 密度 | 1.32 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 83.33 mg/mL (219.06 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (8.68 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容